The BH3 Mimetic Drug ABT-737 Induces Apoptosis and Acts Synergistically With Chemotherapeutic Drugs in Thyroid Carcinoma Cells

Cancer Cell International - United Kingdom
doi 10.1186/s12935-016-0303-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The BH3 Mimetic ABT-737 Increases Treatment Efficiency of Paclitaxel Against Hepatoblastoma

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Chemotherapeutic Drugs Sensitize Human Renal Cell Carcinoma Cells to ABT-737 by a Mechanism Involving the Noxa-Dependent Inactivation of McL-1 or A1

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

ABT-737 Induces Apoptosis in Mantle Cell Lymphoma Cells With a BCL-2high/McL-1low Profile and Synergizes With Other Antineoplastic Agents

Clinical Cancer Research
Cancer ResearchOncology
2011English

BCL-xL-Inhibitory BH3 Mimetics (ABT-737 or ABT-263) and the Modulation of Cytosolic Calcium Flux and Platelet Function

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Comparison of Putative BH3 Mimetics AT-101, HA14-1, Sabutoclax and TW-37 With ABT-737 in Platelets

Platelets
MedicineHematology
2020English

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Interference With the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic–Induced Apoptosis

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

DRP-1 Is Required for BH3 Mimetic-Mediated Mitochondrial Fragmentation and Apoptosis

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy